tradingkey.logo

Venus Concept Inc

VERO
查看詳細走勢圖
1.760USD
-0.020-1.12%
收盤 12/24, 13:00美東報價延遲15分鐘
3.27M總市值
虧損本益比TTM

Venus Concept Inc

1.760
-0.020-1.12%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-1.12%

5天

-3.30%

1月

-3.83%

6月

-20.00%

今年開始到現在

-57.50%

1年

-55.56%

查看詳細走勢圖

TradingKey Venus Concept Inc股票評分

單位: USD 更新時間: 2025-12-24

操作建議

Venus Concept Inc當前公司基本面數據相對穩定,增長潛力較大。當前估值合理,在醫療設備與耗材行業排名138/206位。機構持股佔比非常高,近一個月多位分析師給出公司評級為持有。最高目標價0.00。中期看,股價處於下降通道。近一個月,市場表現較差,基本面和技術面綜合得分也較低。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Venus Concept Inc評分

相關信息

行業排名
138 / 206
全市場排名
357 / 4562
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 2 分析師
持有
評級
0.000
目標均價
0.00%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Venus Concept Inc亮點

亮點風險
Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.
業績增長期
公司處於發展階段,最新年度總收入64.83M美元
估值高估
公司最新PE估值-0.04,處於3年歷史高位
機構加倉
最新機構持股256.25K股,環比增加19.61%
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉2.03K股
活躍度降低
近期活躍度降低,過去20天平均換手率-0.97

Venus Concept Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Venus Concept Inc簡介

Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.
公司代碼VERO
公司Venus Concept Inc
CEODe Silva (Rajiv D)
網址https://www.venusconcept.com/en-uk/

常見問題

Venus Concept Inc(VERO)的當前股價是多少?

Venus Concept Inc(VERO)的當前股價是 1.760。

Venus Concept Inc 的股票代碼是什麼?

Venus Concept Inc的股票代碼是VERO。

Venus Concept Inc股票的52週最高點是多少?

Venus Concept Inc股票的52週最高點是14.500。

Venus Concept Inc股票的52週最低點是多少?

Venus Concept Inc股票的52週最低點是1.650。

Venus Concept Inc的市值是多少?

Venus Concept Inc的市值是3.27M。

Venus Concept Inc的淨利潤是多少?

Venus Concept Inc的淨利潤為-47.00M。

現在Venus Concept Inc(VERO)的股票是買入、持有還是賣出?

根據分析師評級,Venus Concept Inc(VERO)的總體評級為持有,目標價格為--。

Venus Concept Inc(VERO)股票的每股收益(EPS TTM)是多少

Venus Concept Inc(VERO)股票的每股收益(EPS TTM)是-40.285。
KeyAI